Avanos Medical (AVNS) Equity Ratio (2013 - 2026)

Avanos Medical has disclosed Equity Ratio across 14 years of filings, most recently posting 0.74 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.74, down 1.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.74 (down 1.71% YoY), and the FY2025 annual result was 0.72, up 945.0% from the prior year.
• Equity Ratio came in at 0.74 for Q1 2026 at Avanos Medical, up from 0.72 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.93 in Q2 2022 to a low of 0.19 in Q1 2024.
• The 5-year median for Equity Ratio is 0.72 (2022), against an average of 0.46.
• Across the five-year window, Equity Ratio sank 953.64% in 2024 and soared 945.0% in 2025, its largest moves.
• Avanos Medical's Equity Ratio stood at 0.72 in 2022, then climbed by 1.09% to 0.73 in 2023, then slumped by 111.74% to 0.09 in 2024, then surged by 945.0% to 0.72 in 2025, then advanced by 2.76% to 0.74 in 2026.
• The last three Equity Ratio figures came in at 0.74 (Q1 2026), 0.72 (Q4 2025), and 0.73 (Q3 2025), per Business Quant data.